,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
64,.,.,OMIM|low_frequency,.,.,CS000033,180849,Rubinstein-Taybi syndrome 1,"1.$$$mimNumber,180849###prefix,####preferredTitle,RUBINSTEIN-TAYBI SYNDROME 1; RSTS1###inheritance,Autosomal dominant ###growthHeight,Short stature ;###growthHeight,Average adult male height 153 cm ;###growthHeight,Average adult female height 147 cm ###growthWeight,Obesity after puberty ###growthOther,Postnatal growth retardation ###headAndNeckHead,Microcephaly ;###headAndNeckHead,Large anterior fontanelle ;###headAndNeckHead,Late closure of fontanelle ;###headAndNeckHead,Frontal bossing ###headAndNeckFace,Low anterior hairline ;###headAndNeckFace,Hypoplastic maxilla ;###headAndNeckFace,Micrognathia ;###headAndNeckFace,Retrognathia ;###headAndNeckFace,Grimacing or unusual smile with almost closing of the eyes ###headAndNeckEars,Low set ears ;###headAndNeckEars,Hearing loss ;###headAndNeckEars,Recurrent otitis ###headAndNeckEyes,Heavy eyebrows ;###headAndNeckEyes,Highly arched eyebrows ;###headAndNeckEyes,Long eyelashes ;###headAndNeckEyes,Ptosis ;###headAndNeckEyes,Epicanthal folds ;###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Nasolacrimal duct obstruction ;###headAndNeckEyes,Cataracts ;###headAndNeckEyes,Glaucoma ;###headAndNeckEyes,Coloboma ;###headAndNeckEyes,Downward slanting palpebral fissures ###headAndNeckNose,Beaked nose ;###headAndNeckNose,Deviated nasal septum ;###headAndNeckNose,Broad nasal bridge ###headAndNeckMouth,Small opening of the mouth ;###headAndNeckMouth,Narrow palate ;###headAndNeckMouth,High-arched palate ###headAndNeckTeeth,Dental crowding ;###headAndNeckTeeth,Talon cusps ;###headAndNeckTeeth,Crossbite ;###headAndNeckTeeth,Screwdriver permanent incisors ;###headAndNeckTeeth,Enamel hypoplasia ;###headAndNeckTeeth,Enamel discoloration ###cardiovascularHeart,Atrial septal defects ;###cardiovascularHeart,Ventricular septal defects ###cardiovascularVascular,Patent ductus arteriosus ;###cardiovascularVascular,Capillary hemangiomas ###respiratory,Recurrent respiratory infections ###chestRibsSternumClaviclesAndScapulae,Sternal anomalies ###abdomenGastrointestinal,Constipation ###genitourinaryExternalGenitaliaMale,Hypospadias ;###genitourinaryExternalGenitaliaMale,Shawl scrotum ###genitourinaryInternalGenitaliaMale,Cryptorchidism ###skeletal,Delayed skeletal maturation ;###skeletal,Joint hypermobility ###skeletalSkull,Large foramen magnum ;###skeletalSkull,Parietal foramina ###skeletalSpine,Scoliosis ;###skeletalSpine,Spina bifida occulta ###skeletalPelvis,Small, flared iliac wings ###skeletalLimbs,Patellar dislocation ###skeletalHands,Broad thumbs with radial angulation ;###skeletalHands,Fifth finger clinodactyly ;###skeletalHands,Persistent fetal fingertip pads ;###skeletalHands,Syndactyly ;###skeletalHands,Polydactyly ;###skeletalHands,Single transverse palmar creases ###skeletalFeet,Broad great toes ;###skeletalFeet,Plantar crease between first and second toes ;###skeletalFeet,Pes planus ###skinNailsHairSkin,Single transverse palmar creases ;###skinNailsHairSkin,Keloid formation in surgical scars ;###skinNailsHairSkin,Capillary hemangiomas ;###skinNailsHairSkin,Cafe-au-lait spots ###skinNailsHairHair,Hirsutism ###neurologicCentralNervousSystem,Mental retardation (average IQ 51) ;###neurologicCentralNervousSystem,Agenesis of corpus callosum ;###neurologicCentralNervousSystem,Severe expressive speech delay ;###neurologicCentralNervousSystem,Poor coordination ;###neurologicCentralNervousSystem,EEG abnormalities ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Hypotonia ;###neurologicCentralNervousSystem,Hyperreflexia ###neurologicBehavioralPsychiatricManifestations,Good social contacts ;###neurologicBehavioralPsychiatricManifestations,Short attention span ;###neurologicBehavioralPsychiatricManifestations,Labile mood ###immunology,Recurrent infections ;###immunology,Polysaccharide antibody response defect ###neoplasia,Increased risk of tumor formation, especially of the head ;###neoplasia,Increased risk of leukemia ###laboratoryAbnormalities,Ten percent of cases are secondary to submicroscopic deletions of 16p13.3 detectable by FISH ;###laboratoryAbnormalities,A small minority of patients have translocations and inversions involving 16p13.3 ###miscellaneous,Incidence of 1 in 100,000 to 125,000 at birth ;###miscellaneous,Majority of cases are due to de novo mutation ;###miscellaneous,Variable severity ;###miscellaneous,Truncating mutations in CREBBP found in 10% of patients ###molecularBasis,Caused by mutation in the CREB-binding protein gene (CREBBP, ).",https://www.omim.org/entry/180849,.,Autosomal dominant,Het,16,3900336,C,T,.,.,PASS,0/1:31:51,60.78,"t$TTtt,..tT,,tTTT.Tt...Tt...TTTt.T.T.,T.,TttT.T",missense_variant;missense_variant,CREBBP,1387,.,NM_004380.2(CREBBP):c.760G>A(p.Ala254Thr);NM_001079846.1(CREBBP):c.760G>A(p.Ala254Thr),NM_004380.2,exon2(31);exon2(30),NP=>P0;NP=>P0,0.004,0.0016,3,0.00023,0.0007,0.0082,0.0009,0.0117,0,69,0.0080,0,83,0.00069,0.0188457008245,16/849,http://exac.broadinstitute.org/variant/16-3900336-C-T,5.58,83.8,1,1.0,http://exac.broadinstitute.org/gene/ENSG00000005339,0.07773,1.16E-4,0.54,T,0.614,P,0.198,B,0.000,N,0.997,N,3.06,4.000,rs148781922,.,.,.,.,.,.,.,.,.,.,.,.,.,133933,https://www.ncbi.nlm.nih.gov/clinvar/variation/133933,COSM96460,"1(haematopoietic_and_lymphoid_tissue),1(large_intestine)",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"cellular lipid metabolic process (GO:0044255)|cellular response to hypoxia (GO:0071456)|chromatin organization (GO:0006325)|embryonic digit morphogenesis (GO:0042733)|gene expression (GO:0010467)|germ-line stem cell maintenance (GO:0030718)|histone acetylation (GO:0016573)|homeostatic process (GO:0042592)|innate immune response (GO:0045087)|N-terminal peptidyl-lysine acetylation (GO:0018076)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|Notch signaling pathway (GO:0007219)|positive regulation of transcription, DNA-templated (GO:0045893)|positive regulation of type I interferon production (GO:0032481)|protein complex assembly (GO:0006461)|regulation of smoothened signaling pathway (GO:0008589)|regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)|regulation of transcription, DNA-templated (GO:0006355)|response to hypoxia (GO:0001666)|rhythmic process (GO:0048511)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|transcription initiation from RNA polymerase II promoter (GO:0006367)|viral process (GO:0016032)",condensed chromosome outer kinetochore (GO:0000940)|cytoplasm (GO:0005737)|histone acetyltransferase complex (GO:0000123)|nuclear body (GO:0016604)|nuclear chromatin (GO:0000790)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|transcription factor complex (GO:0005667),acetyltransferase activity (GO:0016407)|chromatin binding (GO:0003682)|core promoter proximal region sequence-specific DNA binding (GO:0000987)|histone acetyltransferase activity (GO:0004402)|MRF binding (GO:0043426)|p53 binding (GO:0002039)|RNA polymerase II activating transcription factor binding (GO:0001102)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001078)|RNA polymerase II transcription coactivator activity (GO:0001105)|RNA polymerase II transcription factor binding (GO:0001085)|RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription (GO:0001191)|sequence-specific DNA binding transcription factor activity (GO:0003700)|signal transducer activity (GO:0004871)|transcription coactivator activity (GO:0003713)|transcription factor binding (GO:0008134)|zinc ion binding (GO:0008270),.,.,.,.,82,2,CS000033
136,.,.,HGMD|OMIM,Name=SegmentalDuplications,.,CS000033,608013;230800;230900;231000;231005;127750;168600,"Gaucher disease, perinatal lethal;Gaucher disease, type I;Gaucher disease, type II;Gaucher disease, type III;Gaucher disease, type IIIC;Lewy body dementia, susceptibility to;Parkinson disease, late-onset, susceptibility to","1.$$$mimNumber,608013###prefix,####preferredTitle,GAUCHER DISEASE, PERINATAL LETHAL###inheritance,Autosomal recessive ###growthOther,Intrauterine growth retardation (IUGR) ###headAndNeckHead,Microcephaly ###headAndNeckFace,Dysmorphic facies (30%) ;###headAndNeckFace,Triangular face ;###headAndNeckFace,Retrognathia ;###headAndNeckFace,Micrognathia ###headAndNeckEars,Small ears ;###headAndNeckEars,Low-set ears ;###headAndNeckEars,Malformed ears ###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Hypertelorism ###headAndNeckNose,Flat nasal bridge ;###headAndNeckNose,Anteverted nares ;###headAndNeckNose,Small nose ###headAndNeckMouth,Microstomia ;###headAndNeckMouth,Everted lips ;###headAndNeckMouth,Open mouth ###cardiovascularHeart,Cardiomegaly ###respiratory,Respiratory distress ;###respiratory,Apnea ###respiratoryLung,Lung hypoplasia with fetal hydrops###abdomenLiver,Hepatomegaly ;###abdomenLiver,Liver failure ###abdomenSpleen,Splenomegaly ###abdomenGastrointestinal,Dysphagia ###skeletal,Arthrogryposis ###skinNailsHairSkin,Collodion skin ;###skinNailsHairSkin,Shiny, taut, erythematous skin ;###skinNailsHairSkin,Ichthyosis ;###skinNailsHairSkin,Desquamation of skin soon after birth ;###skinNailsHairSkin,Petechiae ;###skinNailsHairSkin,Purpura ###skinNailsHairSkinHistology,Hyperkeratosis ###neurologicCentralNervousSystem,Progressive neurologic deterioration ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Apathy ;###neurologicCentralNervousSystem,Decreased spontaneous movements at birth ;###neurologicCentralNervousSystem,Hypokinesia ;###neurologicCentralNervousSystem,Akinesia ;###neurologicCentralNervousSystem,Opisthotonos ;###neurologicCentralNervousSystem,Secondary hypertonia ;###neurologicCentralNervousSystem,Loss of primary reflexes ;###neurologicCentralNervousSystem,Enlarged cerebral ventricles ;###neurologicCentralNervousSystem,Loss of neurons ###hematology,Thrombocytopenia ;###hematology,Anemia ###prenatalManifestations,Intrauterine growth retardation ###prenatalManifestationsMovement,Decreased fetal movements ###prenatalManifestationsAmnioticFluid,Hydrops fetalis, nonimmune ;###prenatalManifestationsAmnioticFluid,Polyhydramnios ###prenatalManifestationsDelivery,Premature birth ###laboratoryAbnormalities,Decreased beta-glucocerebrosidase protein and activity ;###laboratoryAbnormalities,Gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system ###miscellaneous,Death in utero (30%) ;###miscellaneous,Hydrops fetalis is associated with death in utero (90%) or within 2 days of birth ;###miscellaneous,In the absence of hydrops, death occurs within 3 months ;###miscellaneous,Most severe form of Gaucher disease ;###miscellaneous,Considered to be a severe form of Gaucher disease type II ()###molecularBasis,Caused by mutation in the acid beta-glucosidase gene (GBA, ) 2.$$$mimNumber,230800###prefix,####preferredTitle,GAUCHER DISEASE, TYPE I###inheritance,Autosomal recessive ###headAndNeckEyes,Brown accumulation of Gaucher cells at corneoscleral limbus ;###headAndNeckEyes,White deposits in corneal epithelium, anterior chamber angle, ciliary body, and pupillary margin ;###headAndNeckEyes,Perimacular grayness ;###headAndNeckEyes,Macular atrophy ;###headAndNeckEyes,Increased retinal vascular permeability ###headAndNeckNose,Epistaxis ###cardiovascularVascular,Increased retinal vascular permeability ;###cardiovascularVascular,Pulmonary hypertension ###respiratoryLung,Pulmonary infiltrates, diffuse (less than 5% of patients) ;###respiratoryLung,Interstitial lung disease ;###respiratoryLung,Restrictive impairment ;###respiratoryLung,Dyspnea ###abdomenLiver,Hepatomegaly ###abdomenSpleen,Splenomegaly ###skeletal,Osteolytic lesions ;###skeletal,Osteonecrosis ;###skeletal,Pathologic fractures ;###skeletal,Bone crises ;###skeletal,Bone pain ###skeletalSpine,Vertebral compression ###skeletalLimbs,Avascular necrosis of femoral head ;###skeletalLimbs,Erlenmeyer flask' deformity of the femurs ###skinNailsHairSkin,Hyperpigmentation ###hematology,Gaucher cells in the bone marrow ;###hematology,Hypersplenism ;###hematology,Thrombocytopenia ;###hematology,Anemia ;###hematology,Pancytopenia ###neoplasia,Increased risk for multiple myeloma ;###neoplasia,Increased risk for monoclonal gammopathy ###laboratoryAbnormalities,Acid beta-glucosidase deficiency ;###laboratoryAbnormalities,Increased bone serum acid phosphatase ###miscellaneous,Age at onset most often in childhood (first decade) ;###miscellaneous,Onset and diagnosis may occur later (after age 20 years) ;###miscellaneous,Highly variable phenotype, some adults may be asymptomatic ;###miscellaneous,Increased frequency in Ashkenazi Jews (carrier frequency 1 in 14) ###molecularBasis,Caused by mutation in the acid beta glucosidase gene (GBA, ) 3.$$$mimNumber,230900###prefix,####preferredTitle,GAUCHER DISEASE, TYPE II###inheritance,Autosomal recessive ###growthWeight,Poor weight gain ###growthOther,Failure to thrive ###headAndNeckEyes,Convergent squint ;###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Ocular paresis ;###headAndNeckEyes,Oculomotor apraxia ###headAndNeckMouth,Trismus ###respiratory,Apnea ###respiratoryLarynx,Laryngeal spasms ###respiratoryLung,Recurrent aspiration pneumonia ###abdomenExternalFeatures,Protruberant abdomen ###abdomenLiver,Hepatomegaly ###abdomenSpleen,Splenomegaly ###abdomenGastrointestinal,Dysphagia ;###abdomenGastrointestinal,Poor feeding ;###abdomenGastrointestinal,Uncoordinated swallowing ###neurologicCentralNervousSystem,Progressive neurologic deterioration ;###neurologicCentralNervousSystem,Psychomotor retardation, severe ;###neurologicCentralNervousSystem,Bulbar signs ;###neurologicCentralNervousSystem,Retroflexion of the neck ;###neurologicCentralNervousSystem,Hyperextension of the neck ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Rigidity ;###neurologicCentralNervousSystem,Cerebral atrophy ;###neurologicCentralNervousSystem,Rapidly progressive brainstem degeneration ###hematology,Thrombocytopenia ;###hematology,Anemia ###laboratoryAbnormalities,Decreased acid beta galactosidase protein and activity ###miscellaneous,Onset between 3 and 6 months of age ;###miscellaneous,Death often by age 2 years ;###miscellaneous,See also perinatal lethal variant (), which is more severe;###miscellaneous,See also Gaucher disease type III (), which is much less severe###molecularBasis,Caused by mutation in the acid beta-glucosidase gene (GBA, ) 4.$$$mimNumber,231000###prefix,####preferredTitle,GAUCHER DISEASE, TYPE III###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthWeight,Decreased weight ###headAndNeckEyes,Abnormal eye movements ;###headAndNeckEyes,Abnormal saccades ;###headAndNeckEyes,Supranuclear gaze palsy, horizontal (type IIIB) ;###headAndNeckEyes,Vertical ocular movements are usually preserved ;###headAndNeckEyes,Squint ###abdomenLiver,Hepatomegaly ###abdomenSpleen,Splenomegaly ###neurologicCentralNervousSystem,Subacute neurologic deterioration ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Delayed motor development ;###neurologicCentralNervousSystem,Intellectual deterioration ;###neurologicCentralNervousSystem,Speech abnormalities ;###neurologicCentralNervousSystem,Ataxia ;###neurologicCentralNervousSystem,Spastic paraparesis ;###neurologicCentralNervousSystem,Myoclonus (subtype 3A) ;###neurologicCentralNervousSystem,Myoclonic seizures (subtype 3A) ;###neurologicCentralNervousSystem,Dementia (subtype 3A) ###neurologicBehavioralPsychiatricManifestations,Depression ###hematology,Gaucher cells in bone marrow ;###hematology,Pancytopenia ;###hematology,Thrombocytopenia ###laboratoryAbnormalities,Decreased beta-glucocerebrosidase protein and activity ###miscellaneous,Highly variable phenotype ;###miscellaneous,Onset usually in childhood (range infancy to late childhood) ;###miscellaneous,Adult onset has been reported ;###miscellaneous,Subtype 3A comprises myoclonus and dementia ;###miscellaneous,Subtype 3B comprises horizontal supranuclear gaze palsy and aggressive systemic disease ;###miscellaneous,Subtype 3C () comprises cardiovascular calcifications###molecularBasis,Caused by mutation in the acid beta-glucocerebrosidase gene (GBA, ) 5.$$$mimNumber,231005###prefix,####preferredTitle,GAUCHER DISEASE, TYPE IIIC###inheritance,Autosomal recessive ###headAndNeckEyes,Supranuclear ophthalmoplegia ;###headAndNeckEyes,Slowed horizontal saccades ;###headAndNeckEyes,Hypometric horizontal saccades ;###headAndNeckEyes,Horizontal nystagmus ;###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Corneal opacities ###cardiovascularHeart,Cardiomegaly ;###cardiovascularHeart,Aortic stenosis due to calcifications ;###cardiovascularHeart,Mitral stenosis due to calcifications ;###cardiovascularHeart,Calcifications of the cardiac valves ###cardiovascularVascular,Calcifications of the aorta ###abdomenLiver,Hepatomegaly ;###abdomenLiver,Gaucher cells ###abdomenSpleen,Splenomegaly ;###abdomenSpleen,Gaucher cells ###skeletalFeet,Pes cavus ###neurologicCentralNervousSystem,Hydrocephalus ;###neurologicCentralNervousSystem,Seizures ###hematology,Bone marrow shows Gaucher cells ;###hematology,Pancytopenia ###laboratoryAbnormalities,Decreased beta-glucosidase protein and activity ###miscellaneous,Onset of abnormal eye movements in early childhood ;###miscellaneous,Onset of cardiac symptoms in adolescence ;###miscellaneous,Cardiac manifestations are often fatal ;###miscellaneous,Visceral manifestations are less apparent ;###miscellaneous,Considered to be a variant of Gaucher disease type III ();###miscellaneous,Associated specifically with the GBA D409H mutation ()###molecularBasis,Caused by mutation in the acid beta-glucosidase gene (GBA, ) 6.$$$mimNumber,127750###prefix,####preferredTitle,DEMENTIA, LEWY BODY; DLB###inheritance,Autosomal dominant ###neurologicCentralNervousSystem,Parkinsonism ;###neurologicCentralNervousSystem,Visual hallucinations ;###neurologicCentralNervousSystem,Delusions ;###neurologicCentralNervousSystem,Progressive dementia ;###neurologicCentralNervousSystem,Fluctuations in consciousness ;###neurologicCentralNervousSystem,Sensitivity to neuroleptic medication ;###neurologicCentralNervousSystem,Diffuse Lewy bodies throughout the brain (cortical and subcortical regions) ###miscellaneous,Onset in the sixth or seventh decades ;###miscellaneous,Phenotypic overlap with Parkinson disease ;###miscellaneous,Allelic disorder to Parkinson disease-1 (PARK1, )###molecularBasis,Caused by mutation in the alpha-synuclein gene (SNCA, );###molecularBasis,Caused by mutation in the beta-synuclein gene (SNCB, ) 7.$$$mimNumber,168600###prefix,####preferredTitle,PARKINSON DISEASE, LATE-ONSET; PD###inheritance,Isolated cases ;###inheritance,Multifactorial ###headAndNeckFace,Masked facies ###headAndNeckNose,Decreased sense of smell ###abdomenGastrointestinal,Dysphagia ;###abdomenGastrointestinal,Constipation ###genitourinaryBladder,Urinary urgency ###neurologicCentralNervousSystem,Parkinsonism ;###neurologicCentralNervousSystem,Bradykinesia ;###neurologicCentralNervousSystem,Rigidity ;###neurologicCentralNervousSystem,Postural instability ;###neurologicCentralNervousSystem,Resting tremor ;###neurologicCentralNervousSystem,Micrographia ;###neurologicCentralNervousSystem,Gait disturbances ;###neurologicCentralNervousSystem,Shuffling gait ;###neurologicCentralNervousSystem,Dystonia ;###neurologicCentralNervousSystem,Dysarthria ;###neurologicCentralNervousSystem,Monotonous speech ;###neurologicCentralNervousSystem,Dysautonomia may occur ;###neurologicCentralNervousSystem,Visual hallucinations may occur ;###neurologicCentralNervousSystem,Dementia may occur ;###neurologicCentralNervousSystem,Sleep disturbances ;###neurologicCentralNervousSystem,Neuronal loss and gliosis in the substantia nigra pars compacta ;###neurologicCentralNervousSystem,Loss of dopaminergic neurons ;###neurologicCentralNervousSystem,Intracellular Lewy bodies ;###neurologicCentralNervousSystem,Aggregation of SNCA-immunopositive inclusions ###neurologicBehavioralPsychiatricManifestations,Depression ###miscellaneous,Onset mid to late adulthood ;###miscellaneous,Insidious onset ;###miscellaneous,Progressive disorder ;###miscellaneous,Levodopa-responsive",https://www.omim.org/entry/608013;https://www.omim.org/entry/230800;https://www.omim.org/entry/230900;https://www.omim.org/entry/231000;https://www.omim.org/entry/231005;https://www.omim.org/entry/127750;https://www.omim.org/entry/168600,.,"Autosomal recessive;Autosomal dominant;Isolated cases, Multifactorial",Het,1,155209780,C,T,.,.,PASS,0/1:28:61,45.9,",$,,,,tt..tT,,,TT,.Tttt.,.,,,T.,,TTT.t.TTttT,.,,.t,TtT,",synonymous_variant;synonymous_variant;5_prime_UTR_variant;synonymous_variant;synonymous_variant,GBA,2629,.,NM_001171812.1(GBA):c.204G>A(p.Pro68=);NM_000157.3(GBA):c.204G>A(p.Pro68=);NM_001171811.1(GBA):c.-58G>A;NM_001005742.2(GBA):c.204G>A(p.Pro68=);NM_001005741.2(GBA):c.204G>A(p.Pro68=),NM_001005741.2,exon3(10);exon3(11);exon2(10);exon4(12);exon4(12),.;.;.;.;.,.,.,0,0,4.063e-06,0,.,.,0,0,0,0,1,0.0000083,0.00117785630153,1/849,http://exac.broadinstitute.org/variant/1-155209780-C-T,2.06,18.8,6,0.03,http://exac.broadinstitute.org/gene/ENSG00000177628,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"NM_001005741.2(GBA):c.203delC,NM_001005741.2(GBA):c.203dupC",DM,"Gaucher disease,Gaucher disease 1","8790604,10796875",.,.,.,COSM161214,1(breast),.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,carbohydrate metabolic process (GO:0005975)|cell death (GO:0008219)|cellular response to tumor necrosis factor (GO:0071356)|ceramide biosynthetic process (GO:0046513)|glucosylceramide catabolic process (GO:0006680)|glycosphingolipid metabolic process (GO:0006687)|negative regulation of inflammatory response (GO:0050728)|negative regulation of interleukin-6 production (GO:0032715)|negative regulation of MAP kinase activity (GO:0043407)|positive regulation of protein dephosphorylation (GO:0035307)|regulation of water loss via skin (GO:0033561)|response to estrogen (GO:0043627)|response to glucocorticoid (GO:0051384)|response to pH (GO:0009268)|response to testosterone (GO:0033574)|response to thyroid hormone (GO:0097066)|skin morphogenesis (GO:0043589)|small molecule metabolic process (GO:0044281)|sphingolipid metabolic process (GO:0006665)|sphingosine biosynthetic process (GO:0046512)|termination of signal transduction (GO:0023021),extracellular vesicular exosome (GO:0070062)|lysosomal lumen (GO:0043202)|lysosomal membrane (GO:0005765),glucosylceramidase activity (GO:0004348)|receptor binding (GO:0005102),.,.,.,.,29,1,CS000033
291,.,.,OMIM|low_frequency,.,.,CS000033,605462;109400;610828,"Basal cell carcinoma, somatic;Basal cell nevus syndrome;Holoprosencephaly 7","1.$$$mimNumber,109400###prefix,####preferredTitle,BASAL CELL NEVUS SYNDROME; BCNS###inheritance,Autosomal dominant ###headAndNeckFace,Broad facies ;###headAndNeckFace,Frontal and biparietal bossing ;###headAndNeckFace,Mild mandibular prognathism ;###headAndNeckFace,Odontogenic keratocysts of jaws ###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Lateral displacement of the inner canthi ;###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Subconjunctival epithelial cysts ;###headAndNeckEyes,Iris coloboma ;###headAndNeckEyes,Glaucoma ;###headAndNeckEyes,Medullated (myelinated) retinal nerve fibers ###headAndNeckNose,Broad nasal root ###headAndNeckMouth,Cleft lip ;###headAndNeckMouth,Cleft palate ###cardiovascularHeart,Cardiac fibroma ###respiratoryLung,Congenital lung cyst ###chestRibsSternumClaviclesAndScapulae,Bifid ribs ;###chestRibsSternumClaviclesAndScapulae,Synostotic ribs ;###chestRibsSternumClaviclesAndScapulae,Hypoplastic ribs ###abdomenGastrointestinal,Lymphomesenteric cysts, often calcified ;###abdomenGastrointestinal,Hamartomatous stomach polyps ###genitourinaryInternalGenitaliaFemale,Ovarian fibromata ;###genitourinaryInternalGenitaliaFemale,Ovarian carcinoma ###skeletalSpine,Scoliosis ;###skeletalSpine,Kyphoscoliosis ;###skeletalSpine,Abnormal cervical vertebrae ###skeletalLimbs,Brachydactyly ;###skeletalLimbs,Short 4th metacarpal ;###skeletalLimbs,Short thumb terminal phalanx ###skinNailsHairSkin,Basal cell nevi ;###skinNailsHairSkin,Basal cell carcinoma ;###skinNailsHairSkin,Pits of palms and soles ###neurologicCentralNervousSystem,Mental retardation (less common) ;###neurologicCentralNervousSystem,Calicification of the falx cerebri ;###neurologicCentralNervousSystem,Medulloblastoma ###miscellaneous,Paternal age effect ;###miscellaneous,Abnormal sensitivity to therapeutic radiation ###molecularBasis,Caused by mutation in the human homolog of the Drosophila 'patched' gene 1 (PTCH1, );###molecularBasis,Caused by mutation in the human homolog of the Drosophila 'patched' gene 2 (PTCH2, );###molecularBasis,Caused by mutation in the human homolog of the Drosophila suppressor of fused gene (SUFU, ) 2.$$$mimNumber,610828###prefix,####preferredTitle,HOLOPROSENCEPHALY 7; HPE7###inheritance,Autosomal dominant ###headAndNeckHead,Macrocephaly ###headAndNeckFace,Midface hypoplasia ;###headAndNeckFace,Hypoplastic premaxilla###headAndNeckEyes,Upslanting palpebral fissures ;###headAndNeckEyes,Hypotelorism ###headAndNeckNose,Hypoplastic nose (in 1 patient) ;###headAndNeckNose,Flattened alae;###headAndNeckNose,Flattened nasal tip ###headAndNeckMouth,Cleft lip ;###headAndNeckMouth,Cleft palate ###headAndNeckTeeth,Single central maxillary incisor ###abdomenExternalFeatures,Omphalocele (in 1 patient) ###neurologicCentralNervousSystem,Holoprosencephaly, semilobar or alobar;###neurologicCentralNervousSystem,Hydrocephalus ;###neurologicCentralNervousSystem,Agenesis of corpus callosum ;###neurologicCentralNervousSystem,Developmental delay ;###neurologicCentralNervousSystem,Seizures ###endocrineFeatures,Panhypopituitarism ###miscellaneous,Incomplete penetrance ###molecularBasis,Caused by mutation in the patched 1 gene (PTCH1, )",https://www.omim.org/entry/605462;https://www.omim.org/entry/109400;https://www.omim.org/entry/610828,.,Autosomal dominant,Het,9,98229391,G,A,.,.,PASS,0/1:51:100,51.0,".$.$.A,AAA,A..A.AA...$..A.AA.A.A.A.AA.,a.,..AA...AAA.A..,A..aAaA,.A,,AAa,a..AAAa.,a.aA.aaAAA.,",splice_region_variant;splice_region_variant;splice_region_variant;splice_region_variant;splice_region_variant;splice_region_variant;splice_region_variant,PTCH1,5727,.,NM_001083605.1(PTCH1):c.2107+7C>T;NM_001083607.1(PTCH1):c.2107+7C>T;NM_001083606.1(PTCH1):c.2107+7C>T;NM_001083602.1(PTCH1):c.2362+7C>T;NM_001083603.1(PTCH1):c.2557+7C>T;NM_001083604.1(PTCH1):c.2107+7C>T;NM_000264.3(PTCH1):c.2560+7C>T,NM_000264.3,intron15(23);intron15(23);intron15(23);intron15(23);intron15(23);intron15(23);intron15(23),.;.;.;.;.;.;.,0.0079,0.0016,0,0,0.0005,0.0067,0.0004,0.0068,1,62,0.0072,1,64,0.00053,0.017667844523,15/849,http://exac.broadinstitute.org/variant/9-98229391-G-A,2.86,42.3,1,1.0,http://exac.broadinstitute.org/gene/ENSG00000185920,.,.,.,.,.,.,.,.,.,.,.,.,.,.,rs75576651,.,.,.,.,.,.,.,.,.,.,.,.,.,135881,https://www.ncbi.nlm.nih.gov/clinvar/variation/135881,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,brain development (GO:0007420)|branching involved in ureteric bud morphogenesis (GO:0001658)|cell differentiation involved in kidney development (GO:0061005)|cell proliferation involved in metanephros development (GO:0072203)|cellular response to cholesterol (GO:0071397)|dorsal/ventral pattern formation (GO:0009953)|embryonic limb morphogenesis (GO:0030326)|embryonic organ development (GO:0048568)|epidermis development (GO:0008544)|glucose homeostasis (GO:0042593)|heart morphogenesis (GO:0003007)|hindlimb morphogenesis (GO:0035137)|in utero embryonic development (GO:0001701)|keratinocyte proliferation (GO:0043616)|limb morphogenesis (GO:0035108)|mammary gland duct morphogenesis (GO:0060603)|mammary gland epithelial cell differentiation (GO:0060644)|negative regulation of cell division (GO:0051782)|negative regulation of epithelial cell proliferation (GO:0050680)|negative regulation of multicellular organism growth (GO:0040015)|negative regulation of osteoblast differentiation (GO:0045668)|negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)|negative regulation of smoothened signaling pathway (GO:0045879)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural plate axis specification (GO:0021997)|neural tube closure (GO:0001843)|neural tube patterning (GO:0021532)|organ morphogenesis (GO:0009887)|pharyngeal system development (GO:0060037)|positive regulation of cholesterol efflux (GO:0010875)|protein processing (GO:0016485)|protein targeting to plasma membrane (GO:0072661)|regulation of mitotic cell cycle (GO:0007346)|regulation of protein localization (GO:0032880)|regulation of smoothened signaling pathway (GO:0008589)|renal system development (GO:0072001)|response to chlorate (GO:0010157)|response to drug (GO:0042493)|response to estradiol (GO:0032355)|response to mechanical stimulus (GO:0009612)|response to retinoic acid (GO:0032526)|smoothened signaling pathway (GO:0007224)|smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:0060831)|somite development (GO:0061053)|spinal cord motor neuron differentiation (GO:0021522),axonal growth cone (GO:0044295)|caveola (GO:0005901)|dendritic growth cone (GO:0044294)|integral component of membrane (GO:0016021)|intracellular membrane-bounded organelle (GO:0043231)|midbody (GO:0030496)|perinuclear region of cytoplasm (GO:0048471)|plasma membrane (GO:0005886)|postsynaptic density (GO:0014069)|primary cilium (GO:0072372),cholesterol binding (GO:0015485)|cyclin binding (GO:0030332)|hedgehog family protein binding (GO:0097108)|hedgehog receptor activity (GO:0008158)|heparin binding (GO:0008201)|smoothened binding (GO:0005119),.,.,.,.,28,0,CS000033
